1. Home
  2. FDMT vs CXDO Comparison

FDMT vs CXDO Comparison

Compare FDMT & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDMT
  • CXDO
  • Stock Information
  • Founded
  • FDMT 2013
  • CXDO 1995
  • Country
  • FDMT United States
  • CXDO United States
  • Employees
  • FDMT N/A
  • CXDO N/A
  • Industry
  • FDMT Biotechnology: Pharmaceutical Preparations
  • CXDO Telecommunications Equipment
  • Sector
  • FDMT Health Care
  • CXDO Telecommunications
  • Exchange
  • FDMT Nasdaq
  • CXDO Nasdaq
  • Market Cap
  • FDMT 192.2M
  • CXDO 190.7M
  • IPO Year
  • FDMT 2020
  • CXDO 1998
  • Fundamental
  • Price
  • FDMT $6.61
  • CXDO $6.49
  • Analyst Decision
  • FDMT Buy
  • CXDO Strong Buy
  • Analyst Count
  • FDMT 9
  • CXDO 4
  • Target Price
  • FDMT $30.63
  • CXDO $8.75
  • AVG Volume (30 Days)
  • FDMT 733.0K
  • CXDO 220.6K
  • Earning Date
  • FDMT 08-11-2025
  • CXDO 08-05-2025
  • Dividend Yield
  • FDMT N/A
  • CXDO N/A
  • EPS Growth
  • FDMT N/A
  • CXDO 13.31
  • EPS
  • FDMT N/A
  • CXDO 0.11
  • Revenue
  • FDMT $33,000.00
  • CXDO $64,476,000.00
  • Revenue This Year
  • FDMT $9,921.62
  • CXDO $13.46
  • Revenue Next Year
  • FDMT N/A
  • CXDO $11.81
  • P/E Ratio
  • FDMT N/A
  • CXDO $59.17
  • Revenue Growth
  • FDMT N/A
  • CXDO 13.10
  • 52 Week Low
  • FDMT $2.24
  • CXDO $3.75
  • 52 Week High
  • FDMT $17.41
  • CXDO $7.34
  • Technical
  • Relative Strength Index (RSI)
  • FDMT 57.82
  • CXDO 60.28
  • Support Level
  • FDMT $5.97
  • CXDO $6.18
  • Resistance Level
  • FDMT $7.33
  • CXDO $6.53
  • Average True Range (ATR)
  • FDMT 0.48
  • CXDO 0.24
  • MACD
  • FDMT -0.11
  • CXDO 0.03
  • Stochastic Oscillator
  • FDMT 39.51
  • CXDO 95.18

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

Share on Social Networks: